Table 2.
Parameter | Placebo (n = 15) | PGD (n = 19) | p |
---|---|---|---|
ALT (U/L) | 38.00 ± 9.70 (32.63–43.37) | 36.32 ± 10.04 (33.06–39.57) | 0.62 |
AST (U/L) | 32.27 ± 9.64 (26.93–37.61) | 35.32 ± 7.97 (32.73–37.90) | 0.32 |
BUN (mmol/L) | 5.93 ± 2.13 (4.75–7.11) | 5.59 ± 1.09 (5.24–5.94) | 0.58 |
CRE (μmol/L) | 71.47 ± 14.91 (63.21–79.72) | 65.91 ± 9.54 (62.82–69.00) | 0.20 |
TG (mmol/L) | 3.20 ± 1.46 (2.39–4.01) | 2.85 ± 1.15 (2.48–3.23) | 0.44 |
GLU (mmol/L) | 4.72 ± 0.67 (4.35–5.10) | 5.08 ± 0.58 (4.89–5.27) | 0.32 |
TSH (uIU/mL) | 6.41 ± 2.27 (5.15–7.66) | 7.31 ± 1.81 (7.08–8.27) | 0.21 |
Data given as n (%) or mean ± standard deviation (95% CI (confidential intervals)).